Replies to post #75542 on Muscle Pharm Corporation (MSLPQ)

[Odessa99]

I also didn't miss the $7.5 million dollar loss and the $9 million decrease in revenues.

Do you give zero credit for the sequential rev rebound to $41 mil from $33 mil, with a backlog of $17 mil (if they can be believed)? After the previous sequential nosedive from $48 mil to $33 mil, if would seem a rise back to $41 mil for Q1 is a bit of a relief. (Especially since some may have expected a continued decline in rev after the disaster Q4.)

They do not have the know how to structure a profitable business.

Agreed... thus far, it has been year-over-year growth by whatever means necessary (including those means detrimental to the shareholder, in the short run.

As always, simply my opinion.

MSLP